C85.99
Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-Hodgkin lymphoma (NHL) refers to a diverse group of blood cancers that originate in the lymphatic system, which is part of the body's immune defense. The specific code C85.99 indicates a case where the lymphoma is unspecified, but it affects extranodal (outside the lymph nodes) and solid organ sites. This type of lymphoma can develop in various tissues such as the stomach, skin, or other organs, making its presentation and treatment complex. Recognizing the signs and understanding the underlying causes can help in early diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations that alter lymphocyte DNA Exposure to certain chemicals such as pesticides and herbicides Chronic infections like Helicobacter pylori or HIV Immunosuppressive therapy or conditions that weaken immune responses Age, with higher incidence in older adults Previous history of cancer or radiation therapy Autoimmune diseases like rheumatoid arthritis and celiac disease
Key Symptoms: Unexplained weight loss Persistent fatigue or weakness Swelling or painless lumps in the neck, armpits, or groin Abdominal pain or swelling Difficulty breathing or coughing if the chest is affected Night sweats and fever Skin changes or rashes in cases of cutaneous involvement Itchiness over affected areas
Diagnostic & Treatment
Diagnosis Path: Diagnosis of non-Hodgkin lymphoma, especially of the unspecified extranodal and solid organ type, involves multiple steps including the following: - Physical examination to identify enlarged lymph nodes or organ swelling - Blood tests to check overall health and detect abnormal cells - Imaging studies such as CT scans, PET scans, or MRI to locate affected tissues - Biopsy of the suspicious tissue to confirm the presence of lymphoma cells and determine the subtype - Additional tests like bone marrow biopsies or molecular studies may be performed to evaluate the extent and specific characteristics of the disease
Treatment Protocols: Treatment options for non-Hodgkin lymphoma, unspecified and involving extranodal and solid organ sites, depend on its subtype, stage, and patient's overall health. Common strategies include: - Chemotherapy to destroy cancerous cells - Targeted therapy that attacks specific molecules involved in tumor growth - Immunotherapy to boost the immune system's response against the lymphoma - Radiation therapy to eliminate localized cancer cells - Stem cell or bone marrow transplants in select cases - Supportive care to manage symptoms and side effects A multidisciplinary team typically guides the choice of treatment, aiming for effective disease management while maintaining quality of life.
Clinical Advice & FAQs
Billing Guidance
Is C85.99 a billable ICD-10 code?
Yes, C85.99 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.99?
Clinical documentation must specify the nature of Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
